Abstract:BACKGROUND Obesity negatively impacts asthma control, but the inflammatory mechanisms are poorly understood. OBJECTIVE To explore which systemic inflammatory mediators mediate the effects of obesity on asthma control. METHODS The subjects with stable asthma (n = 108) underwent assessment of clinical characteristics, which included using The Asthma Control Questionnaire (ACQ)-6. Obesity was defined as a body mass index (BMI) of ≥30 kg/m2, overweight was defined as BMI between 25 to 29.9 kg/m2, and lean weight was defined as BMI < 25 kg/m2. Body composition, including fat mass (FM), visceral fat area (VFA), and percentage body fat (PBF) was analyzed by bioimpedance. Serum interleukin (IL) 4, IL-5, IL-8, IL-13, IL-17, chemokine (C-C motif) ligand (CCL) 17, CCL22, leptin, adiponectin, C-reactive protein (CRP), and interferon (IFN) gamma were measured by using ELISA. Linear regression models were fitted according to the Baron and Kenny procedures for mediation analysis. RESULTS FM (12.73 ± 3.95 versus 18.59 ± 2.95 versus 27.82 ± 5.17 kg; p < 0.0001), VFA (65.99 ± 23.17 versus 93.96 ± 10.28 versus 123.10 ± 18.34 cm2; p < 0.0001), PBF (23.86 ± 7.46 versus 30.74 ± 5.08 versus 36.21 ± 6.28 %; p = 0.0003) and ACQ-6 values (0.83 [0, 1.17]) versus 1.15 [0.50, 1.75] versus 1.33 [0.83, 1.83] score; p = 0.002) were different among lean (n = 52), overweight (n = 37), and obese (n = 19) subjects. Serum levels of leptin, IL-5, IL-13, IL-17, CCL17, CRP, and IFN-gamma in the obese group were significantly elevated compared with the subjects who were lean or overweight (all p < 0.05). The mediation analyses found that the effect of obesity, assessed by BMI, on ACQ-6 was significantly mediated through IL-13 and CCL17. Furthermore, IL-13 and CCL17 mediated the effects of body composition (FM, VFA and PBF) on ACQ-6. The effects of obesity assessed by body composition, but not by using BMI, on ACQ-6 were mediated by leptin. CONCLUSION Our mediation analysis confirmed that systemic inflammation biomarkers, such as leptin, CCL17, IL-4, and IL-13, mediated the effects of obesity on asthma control. This warrants prospective exploration in this distinct asthma phenotype in the future.

A clinician's guide to effects of obesity on childhood asthma and into adulthood

Childhood Obesity and Respiratory Diseases: Which Link?

Obesity-related asthma: new insights leading to a different approach

Increased asthma risk and asthma-related health care complications associated with childhood obesity.

Obesity alters inflammatory response in the pathology of asthma (Review)

Obesity, Inflammation, and Severe Asthma: an Update

Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches.

Association of Obesity and Severe Asthma in Adults

Comparison of Pulmonary Function and Inflammation in Children/Adolescents with New-Onset Asthma with Different Adiposity Statuses

Weight Loss Interventions for Adults With Obesity-Related Asthma

Obesity and Hormonal Influences on Asthma: Mechanisms, Management Challenges, and Emerging Therapeutic Strategies

Obesity-Related Asthma: Immune Regulation And Potential Targeted Therapies

Asthma, obesity and targeted interventions: an update

Effects of biological therapies on patients with Type-2 high asthma and comorbid obesity

Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation

Obesity at the age of 4-5 related to asthma diagnosis in later childhood: A longitudinal study using linked routinely collected data from Wales

Impact of obesity on airway remodeling in asthma: pathophysiological insights and clinical implications

Systemic inflammation mediates the detrimental effects of obesity on asthma control.

Body Weight and Allergic Asthma: A Narrative Review

Targeting Lipid Metabolism in Obese Asthma: Perspectives and Therapeutic Opportunities

Optimizing lifestyle interventions in adult patients with comorbid asthma and obesity